Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tarrant Capital IP is the legal entity that owns and manages trademarks, service marks, and related intellectual property associated with TPG, the global alternative asset manager. It appears to function primarily as an IP-holding and branding entity within the TPG corporate structure rather than as an operating biotechnology, pharmaceutical, or healthcare company. Publicly available materials and TPG website disclosures identify Tarrant Capital IP as the owner of the TPG name, logo, and related marks used across TPG's investment platforms, including healthcare-focused investing. While TPG invests broadly across healthcare, biotech, and life sciences through affiliated platforms, Tarrant Capital IP itself does not appear to develop therapeutics, run a drug pipeline, or provide healthcare products or services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tarrant Capital IP.